Meta-and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: A HuGE-GSEC Review

American Journal of Epidemiology

Volumn 170, Issue 10, 2009, Pages 1207-1221

  Taioli, E ^a   Garza, M A ^b   Ahn, Y O ^c   Bishop, D T ^d   Bost, J ^b   Budai, B ^e   Chen, K ^f   Gemignani, F ^g   Keku, T ^h   Lima, C S P ⁱ   Le Marchand, L ^j   Matsuo, K ^k   Moreno, V ^l   Plaschke, J ^m   Pufulete, M ⁿ   Thomas, S B ^b   Toffoli, G ^o   Wolf, C R ^p   Moore, C G ^b   Little, J ^q  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^f ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CAMPINAS   (Brazil)

^j UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l UNIVERSITY OF BARCELONA   (Spain)

^m DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

^o CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^p Biomedical Research Center   (United Kingdom)

^q UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Colorectal neoplasms; Epidemiologic methods; Epidemiology; Folic acid; Genetic variation; Genetics; Methylenetetrahydrofolate reductase (NADPH2); MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALCOHOL; BODY MASS; CANCER; ENZYME ACTIVITY; EPIDEMIOLOGY; ETHNIC GROUP; GENE; GENETIC VARIATION; GENOTYPE; HEALTH RISK; META-ANALYSIS; MORTALITY; POLYMORPHISM; RISK FACTOR; SMOKING; TEMPORAL RECORD;

ALCOHOL CONSUMPTION; ASIAN; BEHAVIORAL RESEARCH; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HISPANIC; HUMAN; NEGRO; POPULATION GENETIC PARAMETERS; POPULATION RESEARCH; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EPIDEMIOLOGIC METHODS; GENE FREQUENCY; LOGISTIC MODELS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NADP; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 70350694056     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp275     Document Type: Review

References (88)

1. Goyette P, Pai A, Milos R, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome. 1998;9(8):652-656.
2. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000; 71(1-2):121-138.
3. Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ. 2004;328(7433):211-214.
4. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94(7):3290-3295.
5. Stern LL, Mason JB, Selhub J, et al. Genomic DNA hypo-methylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000; 9(8):849-853.
6. Schmutte C, Jones PA. Involvement of DNA methylation in human carcinogenesis. Biol Chem. 1998;379(4-5):377-388.
7. Kawakami K, Ruszkiewicz A, Bennett G, et al. The folate pool in colorectal cancers is associated with DNA hypermethyla-tion and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res. 2003;9(16):5860-5865.
8. Kono S, Chen K. Genetic polymorphisms of methylenetetra-hydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005;96(9):535-542.
9. Fang JY, Xiao SD. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol. 2003;38(9):821-829.
10. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159(5):423-443.
11. Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control. 2006;17(8):1005-1016.
12. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methyle-netetrahydrofolate reductase. Nat Genet. 1995;10(1):111-113.
13. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862-877.
14. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
15. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540.
16. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society; 2007.
17. Capitman J, Bhalotra SM, Calderón-Rosado V, et al. Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities. Waltham, MA: Schneider Institute for Health Policy, Heller School for Social Policy and Management, Brandeis University; 2003.
18. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101(1):3-27.
19. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-156. (Pubitemid 32911406)
20. American Institute for Cancer Research and World Cancer Research Fund. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
21. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83). Lyon, France: IARC Press; 2004.
22. Khaled MA, Krumdieck CL. Association of folate molecules as determined by proton NMR: implications on enzyme binding. Biochem Biophys Res Commun. 1985;130(3): 1273-1280.
23. Abu Khaled M, Watkins CL, Krumdieck CL. Inactivation of B12 and folate coenzymes by butyl nitrite as observed by NMR: implications on one-carbon transfer mechanism. Bio-chem Biophys Res Commun. 1986;135(1):201-207.
24. Halsted CH, Villanueva JA, Devlin AM, et al. Metabolic interactions of alcohol and folate. J Nutr. 2002;132(8 suppl): 2367S-2372S.
25. Barak AJ, Beckenhauer HC, Tuma DJ, et al. Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem Cell Biol. 1987;65(3):230-233.
26. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr. 2002;132(8 suppl):2333S-2335S.
27. Le Marchand L, Wilkens LR, Kolonel LN, et al. The MTHFR C677T polymorphism and colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2005; 14(5):1198-1203. (Pubitemid 40656467)
28. Slattery ML, Edwards SL, Samowitz W, et al. Associations between family history of cancer and genes coding for metabolizing enzymes (United States). Cancer Causes Control. 2000;11(9):799-803.
29. Keku T, Millikan R, Worley K, et al. 5,10-Methylenetetrahy-drofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1611-1621.
30. Hubner RA, Houlston RS. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer. 2007;120(5):1027-1035.
31. Huang Y, Han S, Li Y, et al. Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and co-lorectal cancer: a meta-analysis. J Hum Genet. 2007;52(1): 73-85.
32. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahy-drofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56(21):4862-4864.
33. Kim DH, Ahn YO, Lee BH, et al. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett. 2004;216(2): 199-205.
34. Mannino DM, Mulinare J, Ford ES, et al. Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res. 2003;5(3):357-362.
35. Stark KD, Pawlosky RJ, Beblo S, et al. Status of plasma folate after folic acid fortification of the food supply in pregnant African American women and the influences of diet, smoking, and alcohol consumption. Am J Clin Nutr. 2005;81(3): 669-677.
36. Tungtrongchitr R, Pongpaew P, Soonthornruengyot M, et al. Relationship of tobacco smoking with serum vitamin B12, folic acid and haematological indices in healthy adults. Public Health Nutr. 2003;6(7):675-681.
37. McDonald SD, Perkins SL, Jodouin CA, et al. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol. 2002;187(3):620-625.
38. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahy-drofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57(6):1098-1102.
39. Le Marchand L, Donlon T, Hankin JH, et al. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control. 2002;13(3):239-248.
40. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C/T polymorphism affect cancer risk: intake recommendations. J Nutr. 2003;133(11 suppl 1):3748S-3753S.
41. Mason JB, Choi SW. Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol. 2005;35(3): 235-241.
42. Chiuve SE, Giovannucci EL, Hankinson SE, et al. Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homo-cysteine. Am J Clin Nutr. 2005;82(1):155-162.
43. Hirose M, Kono S, Tabata S, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydro-genase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study. Cancer Sci. 2005;96(8): 513-518.
44. Boyapati SM, Bostick RM, McGlynn KA, et al. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control. 2004;15(5):493-501.
45. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121(2):282-301.
46. Crabtree MD, Fletcher C, Churchman M, et al. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut. 2004;53(2):271-276.
47. Pufulete M, Al-Ghnaniem R, Khushal A, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut. 2005;54(5):648-653.
48. Chen J, Giovannucci E, Hankinson SE, et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis. 1998;19(12):2129-2132.
49. Goode EL, Potter JD, Bigler J, et al. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004; 13(1):157-162.
50. Levine AJ, Siegmund KD, Ervin CM, et al. The methylene-tetrahydrofolate reductase 677C/T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2000;9(7):657-663.
51. Marugame T, Tsuji E, Inoue H, et al. Methylenetetrahydro-folate reductase polymorphism and risk of colorectal adenomas. Cancer Lett. 2000;151(2):181-186.
52. Mitrou PN, Watson MA, Loktionov AS, et al. MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal co-lorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom). Cancer Causes Control. 2006; 17(6):793-801.
53. Ulrich CM, Kampman E, Bigler J, et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev. 1999;8(8):659-668.
54. van den Donk M, Buijsse B, van den Berg SW, et al. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1562- 1566.
55. Ando T, Sugai T, Habano W, et al. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas. J Gas-troenterol. 2005;40(7):708-715.
56. Biasco G, Di Marco MC. Folate and prevention of colorectal cancer in ulcerative colitis. Eur J Cancer Prev. 2005;14(4): 395-398.
57. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8(9):825-829.
58. Budai B, Hitre E, Adleff V, et al. The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of meta-static colorectal tumours [in Hungarian]. Magy Onkol. 2004; 48(3):253-257.
59. Clarizia AD, Bastos-Rodrigues L, Pena HB, et al. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hyperme-thylation in sporadic colorectal cancer. Genet Mol Res. 2006; 5(2):315-322.
60. Taioli E. International collaborative study on genetic susceptibility to environmental carcinogens [letter]. Cancer Epidemiol Biomarkers Prev. 1999;8(8):727-728.
61. Sutton AJ, Abrams KR, Jones DR, et al. Methods for Meta-Analysis in Medical Research. Chichester, United Kingdom: John Wiley & Sons Ltd; 2004.
62. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
63. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007; 335(7626):914-916.
64. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-634.
65. Lima CS, Nascimento H, Bonadia LC, et al. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. Int J Colorectal Dis. 2007;22(7):757-763.
66. Murtaugh MA, Curtin K, Sweeney C, et al. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control. 2007;18(2):153-163.
67. Matsuo K, Ito H, Wakai K, et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogen-esis. 2005;26(12):2164-2171.
68. Otani T, Iwasaki M, Hanaoka T, et al. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer. 2005;53(1): 42-50.
69. Yin G, Kono S, Toyomura K, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2004;95(11):908-913.
70. Wang J, Gajalakshmi V, Jiang J, et al. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. Int J Cancer. 2006;118(4):991-997.
71. Jiang Q, Chen K, Ma X, et al. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev. 2005; 29(2):146-154. (Pubitemid 40514391)
72. Park KS, Mok JW, Kim JC. The 677C > T mutation in 5,10- methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test. 1999;3(2):233-236.
73. Chang SC, Lin PC, Lin JK, et al. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis. 2007;22(5):483-489.
74. Matsuo K, Hamajima N, Hirai T, et al. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev. 2002;3(4): 353-359.
75. Van Guelpen B, Hultdin J, Johansson I, et al. Low folate levels may protect against colorectal cancer. Gut. 2006;55(10):1461-1466.
76. Centers for Disease Control and Prevention. About BMI for Adults. Atlanta, GA: Centers for Disease Control and Prevention; 2007. (http://www.cdc.gov/nccdphp/dnpa/bmi/adult-BMI/ about-adult-BMI.htm). (Accessed April 30, 2008).
77. Ulrich CM, Potter JD. Folate and cancer-timing is everything [editorial]. JAMA. 2007;297(21):2408-2409.
78. Ryan BM, Molloy AM, McManus R, et al. The methylenete-trahydrofolate reductase (MTHFR) gene in colorectal cancer: role in tumor development and significance of allelic loss in tumor progression. Int J Gastrointest Cancer. 2001;30(3): 105-111.
79. Sachse C, Smith G, Wilkie MJ, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis. 2002;23(11):1839-1849.
80. Plaschke J, Schwanebeck U, Pistorius S, et al. Methylenete-trahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Lett. 2003;191(2):179-185.
81. Toffoli G, Gafà R, Russo A, et al. Methylenetetrahydrofolate reductase 677 C/T polymorphism and risk of proximal colon cancer in North Italy. Clin Cancer Res. 2003;9(2):743-748.
82. Ulvik A, Vollset SE, Hansen S, et al. Colorectal cancer and the methylenetetrahydrofolate reductase 677C / T and methionine synthase 2756A / G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2175-2180.
83. Zeybek U, Yaylim I, Yilmaz H, et al. Methylenetetrahydro-folate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct. 2007;25(4):419-422. (Pubitemid 47066718)
84. Sharp L, Little J, Brockton NT, et al. Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. Br J Nutr. 2008;99(2):379-389.
85. Koushik A, Kraft P, Fuchs CS, et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2408-2417.
86. Shannon B, Gnanasampanthan S, Beilby J, et al. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut. 2002;50(4):520-524.
87. Pufulete M, Al-Ghnaniem R, Leather AJ, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 2003;124(5):1240-1248.
88. Landi S, Gemignani F, Moreno V, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Geno-mics. 2005;15(8):535-546.